EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review

Georgios Kalampounias iD, Theodosia Androutsopoulou iD, Panagiotis Katsoris iD

Cells · 14.08.2025 · 14 (16) · 1257

DOI: 10.3390/cells14161257 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 14.08.2025. Verfasst von Georgios Kalampounias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Biology, Division of Genetics, Cell and Developmental Biology, Department of Biology, School of Natural Sciences, University of Pa…. Hauptthemen laut MEDLINE: ets-Domain Protein Elk-1, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 337 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ELK1 is a Transcription factor (TF) belonging to the ETS-domain TF family, mainly activated via RAS-RAF-MEK-ERK signaling. As a nethermost pathway molecule, ELK1 binds to Serum-response elements (SREs) and directly regulates the transcription of Immediate early genes (IEGs) including FOS and EGR1. Due to ELK1’s influence on key cellular processes such as proliferation, migration, apoptosis evasion, and Epithelial-to-mesenchymal transition (EMT), its role as a key contributor to tumorigenesis is emerging. In recent years, elevated expression and/or activation of ELK1 has been reported in various malignancies, including lung, breast, prostate, colorectal, blood, gastric, liver, cervical, thyroid and ovarian cancer. ELK1 acts primarily through direct DNA binding but also through interaction with other oncogenes, noncoding RNA molecules, TFs, and upstream kinases (other than ERK1/2), thus participating in diverse axes of transcriptional regulation. Its crucial role in IEG expression has been particularly implicated in cancer progression, metastasis, and drug resistance. Owing to its role in multiple cellular functions and its subsequent oncogenic potential, further elucidation of intracellular ELK1 interactions is of paramount importance. This review aims to summarize current evidence on ELK1’s involvement in solid tumors, dissect reported mechanistic roles, and highlight recent insights that could fuel future ventures of high translational interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ets-Domain Protein Elk-1NeoplasmsHumansAnimalsGene Expression Regulation, NeoplasticEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

ETS familyMAPKsSRESRFepithelial-to-mesenchymal transitionglioblastomaimmediate early genesinvasiononcogenetumorigenesis

Substanzen

ets-Domain Protein Elk-1ELK1 protein, human

Autor:innen und Institutionen

  • Laboratory of Cell Biology, Division of Genetics, Cell and Developmental Biology, Department of Biology, School of Natural Sciences, University of Patras, 26504 Patras, Greece.
  • Institute for Bioinnovation, Biomedical Sciences Research Centre "Alexander Fleming", 16672 Athens, Greece.

ORCID-Profile: Georgios Kalampounias, Theodosia Androutsopoulou, Panagiotis Katsoris

Zitieren

APA

Kalampounias, G., Androutsopoulou, T., & Katsoris, P. (2025). Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. Cells, 14(16), 1257. https://doi.org/10.3390/cells14161257

Vancouver

Kalampounias G, Androutsopoulou T, Katsoris P. Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. Cells. 2025;14(16):1257. doi:10.3390/cells14161257

BibTeX
@article{Kalampounias2025,
  author = {Kalampounias, Georgios and Androutsopoulou, Theodosia and Katsoris, Panagiotis},
  title = {Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {16},
  pages = {1257},
  doi = {10.3390/cells14161257}
}
Kostenlos starten →